Vancouver, British Columbia, Canada Innovate BC appeared to be the Corporate Investor, which was created in 2004. The main office of represented Corporate Investor is situated in the Vancouver. The fund was located in North America if to be more exact in Canada.
The high activity for fund was in 2019. The common things for fund are deals in the range of 100 thousands - 1 million dollars. The fund is constantly included in less than 2 deals per year.
Among the most popular portfolio startups of the fund, we may highlight Jetti Resources. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Among the most popular fund investment industries, there are Information Technology, Mineral. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are Government of Canada.
Related Funds
| Fund Name | Location |
| Atheneos Ventures | California, Santa Clara, United States |
| BackWeb Technologies | California, San Jose, United States |
| Chase Capital Entertainment Partners | New York, New York, United States |
| Flux Group | - |
| Innovation Inc. | Birmingham, England, United Kingdom |
| PIE | Oregon, Portland, United States |
| PROfounders Capital | England, London, United Kingdom |
| RW Capital Partners | Pennsylvania, Plymouth Meeting, United States |
| S.G.E.C.R. | Community of Madrid, Madrid, Spain |
| Trillium International | Florida, Orlando, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ABOzymes | 15 Jul 2020 | Vancouver, British Columbia, Canada | |||
Careteam Technologies | 29 May 2019 | Vancouver, British Columbia, Canada | |||
DeepND | 01 Jan 2019 | Vancouver, British Columbia, Canada |
– ARTMS received $300,000 funding from Innovate BC.
– The funding will be combined with over $600,000 from additional sources to further develop and validate the production of Zr-89 for use in Positron Emission Tomography (PET) imaging scans of cancer patients eligible for immuno-oncology (IO) therapies.
– “We’re excited to help accelerate game-changing innovation like ARTMS’ proprietary approach to producing critically important, high-quality radiopharmaceutical medical isotopes for cancer patients,” said Mr. Raghwa Gopal, President/CEO of Innovate BC.
– “Past winners have solved critical market problems that other companies have tried to solve for 50 years.”
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ABOzymes | 15 Jul 2020 | Vancouver, British Columbia, Canada | |||
Careteam Technologies | 29 May 2019 | Vancouver, British Columbia, Canada | |||
DeepND | 01 Jan 2019 | Vancouver, British Columbia, Canada |
